AUB ScholarWorks

Venous thromboembolism in cancer patients referred to the American University of Beirut - Medical Center secondary to deep vein thrombosis; occurrence and risk factors

Show simple item record

dc.contributor.author Sleiman W.H.
dc.contributor.author Asfahani Z.
dc.contributor.author Taher A.T.
dc.contributor.author Al Rahawi D.
dc.contributor.author Khalil I.
dc.contributor.editor
dc.date Dec-2005
dc.date.accessioned 2017-10-05T16:07:47Z
dc.date.available 2017-10-05T16:07:47Z
dc.date.issued 2005
dc.identifier 10.1007/s11239-005-4048-9
dc.identifier.isbn
dc.identifier.issn 09295305
dc.identifier.uri http://hdl.handle.net/10938/20035
dc.description.abstract Background-objectives: Cancer is a very important risk factor for the development of thromboembolic disorders. We conducted a retrospective study, in order to examine the rate of Deep vein thrombosis occurrence in cancer patients, as well as the effects of risk factors for DVT in cancer patients affected with DVT. Methods: 148 patients were enrolled in this study. Several risk factors for DVT were retrospectively examined with the main emphasis being age, gender, obesity, previous history of past thromboembolic phenomena and metastatic disease. Results: 55.5percent of the study group was older than 60 years of age. Gender did not appear to be a significant risk factor. As for obesity, only 23percent of our patients were defined as obese. An examination of previous history of thromboembolic conditions revealed that 16.8percent had previous history of DVT, 1.3percent developed a PE prior to presentation and 3.4percent were positive for both DVT and PE. As for metastasis, 33.7percent of our study population exhibited metastatic cancer upon their presentation. One interesting finding was that only 13 patients out of the 148 had been on DVT-prophylaxis prior to their admission. Conclusion: Cancer is an important risk factor for the development of thromboembolic phenomena, yet in most parts of the world, prophylaxis is discerned mostly through clinical judgement or local guidelines. With this in mind, and the additive effects of other risk factors, stricter medical practices and well-defined regimens should be set forth to protect cancer patients from these conditions. © Springer Science + Business Media, Inc. 2005.
dc.format.extent
dc.format.extent Pages: (179-182)
dc.language English
dc.publisher DORDRECHT
dc.relation.ispartof Publication Name: Journal of Thrombosis and Thrombolysis; Publication Year: 2005; Volume: 20; no. 3; Pages: (179-182);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Venous thromboembolism in cancer patients referred to the American University of Beirut - Medical Center secondary to deep vein thrombosis; occurrence and risk factors
dc.type Article
dc.contributor.affiliation Sleiman, W.H., American University of Beirut, Medical Center, P.O. Box: 11-0236-Riad el Solh, 1107-2020 Beirut, Lebanon
dc.contributor.affiliation Asfahani, Z., American University of Beirut, Medical Center, P.O. Box: 11-0236-Riad el Solh, 1107-2020 Beirut, Lebanon
dc.contributor.affiliation Taher, A.T., Division of Hematology and Oncology, American University of Beirut, Medical Center, P.O. Box: 11-0236-Riad el Solh, 1107-2020 Beirut, Lebanon
dc.contributor.affiliation Al Rahawi, D., Department of Surgery, American University of Beirut, Medical Center, P.O. Box: 11-0236-Riad el Solh, 1107-2020 Beirut, Lebanon
dc.contributor.affiliation Khalil, I., Division of Vascular Surgery, American University of Beirut, Medical Center, P.O. Box: 11-0236-Riad el Solh, 1107-2020 Beirut, Lebanon
dc.contributor.authorAddress Khalil, I.; FACS, American University of Beirut, Medical Center, P.O. Box: 11-0236-Riad el Solh, 1107-2020 Beirut, Lebanon; email: ikhalil@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Surgery; Division: Vascular Surgery;
dc.contributor.authorDepartment Surgery
dc.contributor.authorDivision Vascular Surgery
dc.contributor.authorEmail ikhalil@aub.edu.lb
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Sleiman, WH
dc.contributor.authorInitials Asfahani, Z
dc.contributor.authorInitials Taher, AT
dc.contributor.authorInitials Al Rahawi, D
dc.contributor.authorInitials Khalil, I
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Khalil, I (reprint author), Amer Univ Beirut, Med Ctr, Dept Surg, POB 11-0236 Riad el Solh, Beirut 11072020, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016-S0140-6736(97)10018-6; Carmeliet P, 1998, INT J BIOCHEM CELL B, V30, P661, DOI 10.1016-S1357-2725(97)00121-0; Falanga A, 1999, SEMIN THROMB HEMOST, V25, P173, DOI 10.1055-s-2007-994919; FALANGA A, 1985, BIOCHEMISTRY-US, V24, P5558, DOI 10.1021-bi00341a041; Gale AJ, 2001, ACTA HAEMATOL-BASEL, V106, P25, DOI 10.1159-000046586; GORDON SG, 1981, J CLIN INVEST, V67, P1665, DOI 10.1172-JCI110203; Gouin-Thibault I, 2001, ACTA HAEMATOL-BASEL, V106, P33, DOI 10.1159-000046587; Green KB, 1996, HEMATOL ONCOL CLIN N, V10, P499, DOI 10.1016-S0889-8588(05)70349-X; HILLS NH, 1972, BRIT MED J, V1, P131; KAKKAR VV, 1970, AM J SURG, V120, P527, DOI 10.1016-S0002-9610(70)80023-X; MICHAEL J, 2004, ANZ J SURG, V74, P1082; Olas B, 1999, THROMB RES, V94, P199, DOI 10.1016-S0049-3848(98)00214-X; Olas B, 2000, THROMB RES, V97, P169, DOI 10.1016-S0049-3848(99)00129-2; Pritchard KI, 1996, J CLIN ONCOL, V14, P2731; ROSENBERG IL, 1975, BRIT MED J, V1, P649; Shamseddine A, 2004, ANN EPIDEMIOL, V14, P663, DOI 10.1016-j.annepidem.2003.12.002; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056-NEJM199804233381701; SUELING HM, 1986, LANCET, V1, P649; Thodiyil PA, 2001, ACTA HAEMATOL-BASEL, V106, P73, DOI 10.1159-000046592; Trousseau A, 1865, CLIN MED HOTEL DIEU, V3, P654; WILLIAM HG, 2004, CHEST, V126, pS338; Yap Karen P L, 2004, Asian J Surg, V27, P249, DOI 10.1016-S1015-9584(09)60045-2
dc.description.citedCount 2
dc.description.citedTotWOSCount 2
dc.description.citedWOSCount 2
dc.format.extentCount 4
dc.identifier.articleNo
dc.identifier.coden JTTHF
dc.identifier.pubmedID 16261292
dc.identifier.scopusID 27944454831
dc.identifier.url
dc.publisher.address VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr J. Thromb. Thrombolysis
dc.relation.ispartOfIssue 3
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Journal of Thrombosis and Thrombolysis
dc.relation.ispartofPubTitleAbbr J. Thromb. Trombolysis
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 20
dc.source.ID WOS:000232986500006
dc.type.publication Journal
dc.subject.otherAuthKeyword Cancer
dc.subject.otherAuthKeyword Deep vein thrombosis
dc.subject.otherAuthKeyword Prophylaxis
dc.subject.otherAuthKeyword Risk factors
dc.subject.otherChemCAS
dc.subject.otherIndex antineoplastic agent
dc.subject.otherIndex adult
dc.subject.otherIndex age
dc.subject.otherIndex aged
dc.subject.otherIndex anamnesis
dc.subject.otherIndex article
dc.subject.otherIndex brain cancer
dc.subject.otherIndex cancer
dc.subject.otherIndex cancer chemotherapy
dc.subject.otherIndex cancer hormone therapy
dc.subject.otherIndex cancer patient
dc.subject.otherIndex cancer radiotherapy
dc.subject.otherIndex colon cancer
dc.subject.otherIndex deep vein thrombosis
dc.subject.otherIndex disease association
dc.subject.otherIndex female
dc.subject.otherIndex human
dc.subject.otherIndex Lebanon
dc.subject.otherIndex lung cancer
dc.subject.otherIndex major clinical study
dc.subject.otherIndex male
dc.subject.otherIndex metastasis
dc.subject.otherIndex obesity
dc.subject.otherIndex ovary cancer
dc.subject.otherIndex pancreas cancer
dc.subject.otherIndex patient referral
dc.subject.otherIndex priority journal
dc.subject.otherIndex prostate cancer
dc.subject.otherIndex retrospective study
dc.subject.otherIndex risk assessment
dc.subject.otherIndex risk factor
dc.subject.otherIndex uterine cervix cancer
dc.subject.otherIndex Adult
dc.subject.otherIndex Aged
dc.subject.otherIndex Case-Control Studies
dc.subject.otherIndex Female
dc.subject.otherIndex Humans
dc.subject.otherIndex Male
dc.subject.otherIndex Middle Aged
dc.subject.otherIndex Neoplasms
dc.subject.otherIndex Retrospective Studies
dc.subject.otherIndex Risk Factors
dc.subject.otherIndex Thromboembolism
dc.subject.otherIndex Venous Thrombosis
dc.subject.otherKeywordPlus THROMBOPHILIC STATE
dc.subject.otherKeywordPlus MALIGNANT-TISSUE
dc.subject.otherKeywordPlus PROCOAGULANT
dc.subject.otherKeywordPlus TRIAL
dc.subject.otherKeywordPlus CALF
dc.subject.otherKeywordPlus LEG
dc.subject.otherWOS Hematology
dc.subject.otherWOS Peripheral Vascular Disease


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account